MiMedx Group Inc (NASDAQ:MDXG) : MiMedx Group Inc (NASDAQ:MDXG) had a healthy money flow of $0.26 million into the stock during the Wednesdays trading session. The value of bullish trades on upticks was $0.48 million, whereas, investors only sold shares worth $0.23 million on downticks. The stock closed the day with an up-down ratio of 2.13.The money flow in the block trades to the tune of $0.01 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $0.01 million worth of transactions were on upticks. MiMedx Group Inc (NASDAQ:MDXG) stock slid $0.01 intraday and traded at 7.68, a change of -0.13% over previous days close. However, for the week, the company shares are 1.45% compared to previous weeks close.
In an insider trading activity, The Securities and Exchange Commission has divulged that Taylor William Charles, director officer (President and COO) of Mimedx Group, Inc., had unloaded 24,333 shares at an average price of $7.52 in a transaction dated on June 16, 2016. The total value of the transaction was worth $182,984. Currently the company Insiders own 12.3% of MiMedx Group Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 2.1% . Institutional Investors own 41.46% of MiMedx Group Inc shares. During last six month period, the net percent change held by insiders has seen a change of 2.1%.
The company shares have dropped -30.34% from its 1 Year high price. On Jul 17, 2015, the shares registered one year high at $13.20 and the one year low was seen on May 13, 2016. The 50-Day Moving Average price is $7.54 and the 200 Day Moving Average price is recorded at $8.15. MiMedx Group Inc (NASDAQ:MDXG): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $7.65 and $7.56 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $7.88. The buying momentum continued till the end and the stock did not give up its gains. It closed at $7.88, notching a gain of 2.47% for the day. The total traded volume was 915,896 . The stock had closed at $7.69 on the previous day.
MiMedx Group, Inc. (MiMedx) is an integrated developer, manufacturer and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane. The Companys biomaterial platform technologies include AmnioFix and EpiFix, its tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through its donor program, mothers delivering full-term Cesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce an implant, which is referred as an allograft. MiMedx is the supplier of amniotic tissue, having supplied over 350,000 allografts for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare. Its CollaFix technology combines a means of creating fibers from soluble collagen and a cross-linking process.